 | Up a level |
2022
Koehm, M., Rossmanith, T., Foldenauer, A. C., Kellner, H., Kiltz, U., Rech, J., Burmester, G. R., Kofler, D. M., Brandt-Juergens, J., Jonetzko, C., Burkhardt, H. and Behrens, F. (2022). EFFICACY OF UST IN ACTIVE PSA IS INDEPENDENT FROM CONCOMITANT MTX USE, EVEN IN PATIENTS WITH MORE SEVERE SKIN PSORIASIS: SUBGROUP ANALYSIS FROM A RANDOMIZED PLACEBO-CONTROLLED INVESTIGATOR INITIATED CLINICAL TRIAL. Ann. Rheum. Dis., 81. S. 850 - 852. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
Rech, J., Kleyer, A., Ostergaard, M., Hagen, M., Valor, L., Tascilar, K., Kronke, G., Schonau, V., Kleinert, S., Baraliakos, X., Braun, J., Fleck, M., Rubbert-Roth, A., Behrens, F., Feuchtenberger, M., Zaenker, M., Kofler, D. M., Voll, R., Glaser, C., Hueber, A., Feist, E., Burmester, G. R., Karberg, K., Strunk, J., Canete, J. D. D., Senolt, L., Naredo, E. and Schett, G. (2022). ABATACEPT DELAYS THE DEVELOPMENT OF RA-CLINICAL RESULTS AFTER 18 MONTHS FROM THE RANDOMIZED, PLACEBO-CONTROLLED ARIAA STUDY IN RA-AT RISK PATIENTS. Ann. Rheum. Dis., 81. S. 526 - 528. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
2016
Henkemeier, U., Alten, R., Bannert, B., Baraliakos, X., Behrens, F., Heldmann, F., Kiltz, U., Koehm, M., Koenig, R., Leipe, J., Mueller-Ladner, U., Rech, J., Riechers, E., Rubbert-Roth, A., Schmidt, R. E., Schulze-Koops, H., Specker, C., Tausche, A. -K, Wassenberg, S., Witt, M., Witte, T., Zernicke, J. and Burkhardt, H. (2016). Do we still need clinical studies in rheumatology? Z. Rheumatol., 75 (1). S. 4 - 11. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1435-1250
Liphardt, A. -M., Bruggemann, G. -P., Zaucke, F., Eckstein, F., Bloch, W., Mundermann, A., Mester, J., Schett, G., Rech, J. and Niehoff, A. (2016). IMPACT OF IMMOBILIZATION ON SERUM LEVELS OF CARTILAGE OLIGOMERIC MATRIX PROTEIN AND IMPLICATIONS FOR CLINICAL PRACTICE IN MUSCULOSKELETAL DISORDERS. Ann. Rheum. Dis., 75. S. 184 - 186. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
2014
Alexander, T., Sarfert, R., Klotsche, J., Rubbert-Roth, A., Lorenz, H. -M., Rech, J., Hoyer, B., Cheng, Q., Waka, A., Taddeo, A., Kuehl, A. A., Schett, G., Burmester, G. -R., Radbruch, A., Hiepe, F. and Voll, R. E. (2014). THE PROTEASOME INHIBITOR BORTEZOMIB AMELIORATES REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A PROSPECTIVE MULTI-CENTRE OBSERVATIONAL STUDY. Ann. Rheum. Dis., 73. S. 530 - 531. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060